Fumio Ishii

This inventor holds 6 USPTO granted patents. Top assignees: Ss Pharmaceutical Co., Ltd., Ssp Co. Ltd, Hisamitsu Medical Co., Ltd.. Active years: 1989-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumio Ishii. Retrieved from https://idiyas.com/inventor/fumio-ishii-8uiu9ukd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Ageo, JP (1989)
Sendai, JP (1999 - 2000)
Miyagi, JP (2005)

Company Filing History:

3 out of 90

Ss Pharmaceutical Co., Ltd.

Hisamitsu Medical Co., Ltd.

patent

Years Active: 1989-2005

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6958353 - Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts (2005-10-25),

2. 6124347 - Chromene derivatives and salts thereof, and pharmaceuticals containing (2000-09-26),

3. 5962509 - Dithiolylidene acetamide derivatives (1999-10-05),

4. 5922767 - Substituted benzylurea derivatives and medicine containing the same (1999-07-13),

5. 5866609 - Substituted vinylurea derivatives and medicine containing the same (1999-02-02),

6. 4849512 - 3-acylamino-3-deoxyallose derivatives (1989-07-18),

Title: Fumio Ishii: Innovator in Pharmaceutical Chemistry

Introduction

Fumio Ishii is a notable inventor based in Sendai, Japan, recognized for his contributions to pharmaceutical chemistry. He holds a total of six patents, showcasing his innovative approach to drug development and therapeutic solutions.

Latest Patents

Ishii's latest patents include significant advancements in the field of medicinal chemistry. One of his notable inventions is related to imidazole derivatives or salts thereof, which are aimed at developing drugs that inhibit the production of nitric oxide (NO) and interleukin-6 (IL-6). These compounds are particularly useful in preventing or treating diseases associated with the overproduction of these substances. Another important patent involves chromene derivatives and their salts, which demonstrate excellent inhibitory action against advanced glycation end products (AGEs) and are beneficial in preventing diabetic complications.

Career Highlights

Throughout his career, Fumio Ishii has worked with prominent companies such as Ss Pharmaceutical Co., Ltd. and Ssp Co. Ltd. His work has significantly impacted the pharmaceutical industry, particularly in the development of new therapeutic agents.

Collaborations

Ishii has collaborated with esteemed colleagues, including Susumu Sato and Mari Ohtsuka, contributing to various research projects and innovations in the field.

Conclusion

Fumio Ishii's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]